Healthcare entity
All 1 tracked stories fall under one category: regulation. Danish Medicines Agency is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Gestodene, all published on August 1, 2026.
Last mentioned: Aug 1, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Danish Medicines Agency is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Gestodene, all published on August 1, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 14 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Gestodene. Shared-story counts are live from our verified record — not editorial picks.
A massive Danish registry study finds that several widely used hormonal contraceptives, not just Depo-Provera, elevate the risk of meningioma. This compels clinicians to revise prescribing practices and patient counseling amid rising litigation.
Gestodene is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
